GCP
ELV icon

Garda Capital Partners’s Elevance Health ELV Stock Holding History

Garda Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,500
Closed -$780K – 306
2024
Q3 		$780K Sell
1,500
-1,600
-52% -$855K 0.02% 429
2024
Q2 		$1.68M Buy
3,100
+1,500
+94% +$793K 0.06% 273
2024
Q1 		$830K Sell
1,600
-1,900
-54% -$945K 0.03% 290
2023
Q4 		$1.65M Hold
3,500
– – 0.14% 156
2023
Q3 		$1.52M Buy
3,500
+3,000
+600% +$1.36M 0.07% 270
2023
Q2 		$222K Buy
+500
New +$231K 0.01% 330

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM